IN8BIO INC. - COMMON
0.2550
07-October-24 14:59:48
15 minutes delayed
Stocks
-0.0083
-3.15%
Today's range
0.2402 - 0.2760
ISIN
N/A
Source
NASDAQ
-
IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
04 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
11 Dec 2023 15:05:00 By Nasdaq GlobeNewswire
-
IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
11 Dec 2023 08:00:47 By Nasdaq GlobeNewswire
-
IN8bio Appoints Dr. Corinne Epperly to Board of Directors
07 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
20 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
09 Nov 2023 15:00:00 By Nasdaq GlobeNewswire
-
06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 11:00:00 By Nasdaq GlobeNewswire
-
02 Nov 2023 08:17:21 By Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Truist Securities BioPharma Symposium
01 Nov 2023 07:00:01 By Nasdaq GlobeNewswire
-
IN8bio Announces Presentations at the Society for Immunology of Cancer (SITC) 38th Annual Meeting
29 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 07:00:01 By Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global Patents
19 Sep 2023 07:03:33 By Nasdaq GlobeNewswire
-
IN8bio to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
15 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
10 Aug 2023 15:15:37 By Nasdaq GlobeNewswire